research LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.
Lucknow, Uttar Pradesh, India
Shahuwadi, Maharashtra, India
Bhubaneswar, Odisha, India
Lal Bahadur Nagar, Telangana, India
Meridian, MS, United States
Imperial, PA, United States